TY - JOUR
T1 - Kisspeptin-10 binding to Gpr54 in osteoclasts prevents bone loss by activating Dusp18-mediated dephosphorylation of Src
AU - Li, Zhenxi
AU - Yang, Xinghai
AU - Fu, Ruifeng
AU - Wu, Zhipeng
AU - Xu, Shengzhao
AU - Jiao, Jian
AU - Qian, Ming
AU - Zhang, Long
AU - Wu, Chunbiao
AU - Xie, Tianying
AU - Yao, Jiqiang
AU - Wu, Zhixiang
AU - Li, Wenjun
AU - Ma, Guoli
AU - You, Yu
AU - Chen, Yihua
AU - Zhang, Han Kun
AU - Cheng, Yiyun
AU - Tang, Xiaolong
AU - Wu, Pengfei
AU - Lian, Gewei
AU - Wei, Haifeng
AU - Zhao, Jian
AU - Xu, Jianrong
AU - Ai, Lianzhong
AU - Siwko, Stefan
AU - Wang, Yue
AU - Ding, Jin
AU - Song, Gaojie
AU - Luo, Jian
AU - Liu, Mingyao
AU - Xiao, Jianru
N1 - Publisher Copyright:
© The Author(s) 2024.
PY - 2024/12
Y1 - 2024/12
N2 - Osteoclasts are over-activated as we age, which results in bone loss. Src deficiency in mice leads to severe osteopetrosis due to a functional defect in osteoclasts, indicating that Src function is essential in osteoclasts. G-protein-coupled receptors (GPCRs) are the targets for ∼35% of approved drugs but it is still unclear how GPCRs regulate Src kinase activity. Here, we reveal that GPR54 activation by its natural ligand Kisspeptin-10 (Kp-10) causes Dusp18 to dephosphorylate Src at Tyr 416. Mechanistically, Gpr54 recruits both active Src and the Dusp18 phosphatase at its proline/arginine-rich motif in its C terminus. We show that Kp-10 binding to Gpr54 leads to the up-regulation of Dusp18. Kiss1, Gpr54 and Dusp18 knockout mice all exhibit osteoclast hyperactivation and bone loss, and Kp-10 abrogated bone loss by suppressing osteoclast activity in vivo. Therefore, Kp-10/Gpr54 is a promising therapeutic target to abrogate bone resorption by Dusp18-mediated Src dephosphorylation.
AB - Osteoclasts are over-activated as we age, which results in bone loss. Src deficiency in mice leads to severe osteopetrosis due to a functional defect in osteoclasts, indicating that Src function is essential in osteoclasts. G-protein-coupled receptors (GPCRs) are the targets for ∼35% of approved drugs but it is still unclear how GPCRs regulate Src kinase activity. Here, we reveal that GPR54 activation by its natural ligand Kisspeptin-10 (Kp-10) causes Dusp18 to dephosphorylate Src at Tyr 416. Mechanistically, Gpr54 recruits both active Src and the Dusp18 phosphatase at its proline/arginine-rich motif in its C terminus. We show that Kp-10 binding to Gpr54 leads to the up-regulation of Dusp18. Kiss1, Gpr54 and Dusp18 knockout mice all exhibit osteoclast hyperactivation and bone loss, and Kp-10 abrogated bone loss by suppressing osteoclast activity in vivo. Therefore, Kp-10/Gpr54 is a promising therapeutic target to abrogate bone resorption by Dusp18-mediated Src dephosphorylation.
UR - https://www.scopus.com/pages/publications/85185139179
U2 - 10.1038/s41467-024-44852-9
DO - 10.1038/s41467-024-44852-9
M3 - 文章
C2 - 38346942
AN - SCOPUS:85185139179
SN - 2041-1723
VL - 15
JO - Nature Communications
JF - Nature Communications
IS - 1
M1 - 1300
ER -